News from NIAID-Supported Institutions

News from NIAID-Supported Institutions

News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Know Your Enemy: Combating Whooping Cough Requires Informed Vaccine Booster Schedules 
January 19, 2015—University of Michigan

Rare Mutations Do Not Explain “Missing Heritability” in Asthma
January 16, 2015—University of Chicago

"Universal Flu Vaccine" May Be Closer Than We Think, Says Mac Researcher
January 15, 2015—McMaster University

Tumor Suppressor Protein Helps Immune System Stay Balanced
January 15, 2015—St. Jude Children’s Research Hospital

Long-Acting Drug Effectively Prevents HIV-Like Infection in Monkeys
January 15, 2015—The Rockefeller University

Vaccine-Induced CD4 T Cells Lead to Adverse Effect in a Mouse Model of Infection
January 15, 2015—Beth Israel Deaconess Medical Center

Contract Research Organization WCCT Global Announced Collaboration Agreement with the NIAID for Influenza Challenge Research 
January 15, 2015—WCCT Global

Human Mode of Responding to HIV Vaccine Is Conserved From Monkeys
January 15, 2015—Duke Medicine

3D Systems Partners with National Institutes of Health (NIH) to Advance Medical Innovations Through 3D Printing 
January 15, 2015—3D Systems

Possible Treatments Identified for Highly Contagious Stomach Virus 
January 13, 2015—Washington University School of Medicine in St. Louis

Study Links Common Human Protein to Adverse Parasitic Worm Infections
January 8, 2015—University of California, Riverside

The Best Offense Against Bacteria is a Good Defense
January 7, 2015—The Ohio State University

New Approach May Lead to Inhalable Vaccines for Influenza, Pneumonia
January 7, 2015—University of North Carolina at Chapel Hill

Newly Discovered Antibiotic Kills Pathogens Without Resistance
January 7, 2015—Northeastern University

Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen 
Jan. 6, 2015—Johnson & Johnson

Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-BN® Filo and Janssen’s AdVac® Technology
January 6, 2015—Bavarian Nordic

Nearly Half-Million Dollar NIH Grant Awarded to Study Widespread Virus Affecting Infants
January 6, 2015—Ohio University Heritage College of Osteopathic Medicine

Cold Virus Replicates Better at Cooler Temperatures
January 5, 2015—Yale University

Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome
January 5, 2015—Soligenix, Inc.

Fat Isn’t All Bad: Skin Adipocytes Help Protect Against Infections
January 5, 2015—University of California, San Diego School of Medicine

HIV Vaccines Should Avoid Viral Target Cells, Primate Model Study Suggests
January 2, 2015—Emory University

Purdue Research Suggests Approach to Treat Virus Causing Respiratory Illness, Possible Paralysis in Children
January 1, 2015—Purdue University